cyclosporine has been researched along with Infection in 126 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 47 (37.30) | 18.2507 |
| 2000's | 50 (39.68) | 29.6817 |
| 2010's | 27 (21.43) | 24.3611 |
| 2020's | 2 (1.59) | 2.80 |
| Authors | Studies |
|---|---|
| Li, HY; Zhang, X; Zhong, H; Zhong, Z; Zhou, T | 1 |
| Malpica, L; Moll, S | 1 |
| Brunello, L; Bruno, B; Busca, A; Butera, S; Cerrano, M; Dellacasa, CM; Faraci, DG; Giaccone, L; Mordini, N; Sorasio, R; Vassallo, S; Zallio, F | 1 |
| Aguas, M; Aguirresarobe, M; Bermejo, F; Calvet, X; Cañas-Ventura, A; Chaparro, M; De Castro, ML; Domènech, E; Esteve, M; Fernández, L; Fernández-Bañares, F; Garcia-Planella, E; García-Sánchez, V; García-Sepulcre, MF; Gento, E; Gomollón, F; Gutiérrez, A; Iglesias-Flores, E; Jiménez, CE; Mañosa, M; Merino, O; Mir, A; Montoro, MA; Muñoz, C; Muñoz, F; Ordás, I; Panés, J; Peñalva, M; Vera, M | 1 |
| Barraco, F; Bay, JO; Braun, T; Cahn, JY; Deconinck, E; Galambrun, C; Jubert, C; Lamy, T; Leblanc, T; Marcais, A; Mohty, M; Nguyen, S; Pasquet, M; Peffault de Latour, R; Sicre de Fontbrune, F; Socié, G; Tabrizi, R; Tavitian, S | 1 |
| Anand, A; Jain, P; Panchal, H; Parikh, S; Patel, A; Patel, K; Shah, K; Shah, S | 1 |
| Bian, Z; Lu, S; Qiao, X; Song, X; Zhou, H; Zhou, N | 1 |
| Hu, B; Kuang, F; Liu, D; Qing, S; Yang, Y; Yu, X | 1 |
| Cheng, L; He, GS; Lin, SY; Liu, J; Liu, XQ; Lu, XY; Wu, XM; Yang, Y; Yin, H | 1 |
| Riella, LV; Sayegh, MH | 1 |
| Bellia, G; Chimenti, S; Colombo, D; Di Nuzzo, S; Gargiulo, A; Griseta, V; Grossi, P; Marchesoni, A; Parodi, A; Simoni, L | 1 |
| Altomare, G; Ayala, F; Bardazzi, F; Bellia, G; Chimenti, S; Colombo, D; Flori, ML; Girolomoni, G; Micali, G; Parodi, A; Peris, K; Vena, GA | 1 |
| Avgerinou, G; Efstathiou, E; Gamaletsou, MN; Giamouris, VJ; Goussetis, E; Graphakos, S; Kitra, V; Paisiou, A; Peristeri, I; Sipsas, NV; Vessalas, G; Zisaki, K | 1 |
| Dreyer, J; Gruenewald, T; Herscovici, C; Israeli, M; Levy-Assaraf, M; Mechoulam, R; Peck, A; Raanani, P; Ram, R; Shargian, L; Shpilberg, O; Yeshurun, M | 1 |
| Aliño, SF; Almenar, L; Bosó, V; Herrero, MJ; Jordán-De Luna, C; Martínez-Dolz, L; Megías-Vericat, JE; Miguel, A; Poveda, JL; Rojas, L; Sánchez-Lázaro, I; Sendra, L | 1 |
| Bobrowska, K; Cyganek, A; Czaplinska, N; Drozdowska-Szymczak, A; Jabiry-Zieniewicz, Z; Kociszewska-Najman, B; Pietrzak, B; Schreiber-Zamora, J; Wielgos, M | 1 |
| Arora, M; Bejanyan, N; Blazar, BR; Brunstein, CG; DeFor, TE; Holtan, SG; Jacobson, PA; Lazaryan, A; MacMillan, ML; Rogosheske, J; Verneris, MR; Wagner, JE; Weisdorf, DJ | 1 |
| Alberu, J; Del Carmen Rial, M; Grinyó, JM; Jones-Burton, C; Kamar, N; Manfro, RC; Nainan, G; Steinberg, SM; Vincenti, F | 1 |
| Gottlieb, AB; Korman, N; Krueger, GG; Sterry, W; Van De Kerkhof, P | 1 |
| Abdulmola, TS; Ajaj, H; Altajori, O; Elusta, A; Ethuish, EF; Milud, N; Mishra, A; Shawish, T; Shebani, A | 1 |
| Buell, C; Koo, J | 1 |
| Fan, Y; Weng, YG; Xiao, YB | 1 |
| Bernasconi, C; Ekberg, H; Erken, U; Ketteler, M; Mjörnstedt, L; Navrátil, P; Nöldeke, J; Yussim, A | 1 |
| Billing, H; Feneberg, R; Giese, T; Meuer, S; Sommerer, C; Tönshoff, B; Zeier, M | 1 |
| Alvarez, F; Ciocca, ME; Cuarterolo, ML; de Dávila, MT; López, SI | 1 |
| Agarwal, M; Apanovitch, AM; Charpentier, B; Grinyó, J; Gujrathi, S; Larsen, CP; Pestana, JM; Reyes-Acevedo, R; Thomas, D; Vanrenterghem, Y; Vincenti, F | 1 |
| Allez, M; Bouguen, G; Bouhnik, Y; Bourreille, A; Chaussade, S; Colombel, JF; Dewit, O; Duclos, B; Dupas, JL; Flourié, B; Leblanc, S; Lémann, M; Mary, JY; Michetti, P; Peeters, H; Peyrin-Biroulet, L; Saussure, P; Seksik, P | 1 |
| Banner, NR; Bonser, RS; Emin, A; Rogers, CA; Thekkudan, J | 1 |
| Brown, R; Burke, GW; Chen, L; Ciancio, G; Gaynor, JJ; Guerra, G; Hanson, L; Kupin, W; Livingstone, AS; Roth, D; Ruiz, P; Sageshima, J; Tueros, L; Zarak, A | 1 |
| Billing, H; Breil, T; Engelmann, G; Giese, T; Schmidt, J; Schmitt, C; Schmitt, CP; Tönshoff, B | 1 |
| Kessler, CS; Khan, BA; Lai-Miller, K | 1 |
| Caballero, D; Cabrero, M; Lopez-Corral, L; Márquez-Malaver, FJ; Martinez, C; Martino, R; Parody, R; Perez-Simón, JA; Sierra, J; Solano, C; Valcarcel, D; Vazquez, L | 1 |
| Rajagopala, S; Singh, N | 1 |
| Abbud Filho, M; Campos, HH | 1 |
| Berger, C; Goetschel, P; Laube, GF; Leumann, E; Neuhaus, TJ | 1 |
| Caballero, D; Chopra, R; Craddock, C; García-Conde, J; Goldstone, AH; Hunter, A; Kottaridis, PD; Leon, A; Linch, DC; Mackinnon, S; Martino, R; Milligan, DW; Parker, A; Pérez-Simón, JA; San Miguel, JF; Schey, S; Sierra, J; Sureda, A; Urbano-Ispizua, A; Yong, K | 1 |
| Asano, M; Bailey, LL; Cannarella, SN; Fagoaga, O; Gundry, SR; Izutani, H | 1 |
| Daly, AS; Hasegawa, W; Jamal, H; Kiss, TL; Kotchetkova, N; Lipton, JH; Messner, HA; Yi, QL | 1 |
| Abboud, M; Locatelli, F; Muwakkit, S; Razzouk, B; Wilimas, J | 1 |
| Burke, E; Burkhoff, D; Edwards, N; Itescu, S; LaManca, J; Mancini, D; Marks, AR; Oz, M; Pinney, S | 1 |
| Briffa, NK; Eisman, JA; Keogh, AM; Sambrook, PN | 1 |
| Alonso-Pulpón, L; Arroyo, R; Burgos, R; Fuertes, B; Moñivas, V; Ortiz, P; Peraira, JR; Segovia, J | 1 |
| Alard, P; Bazin, H; Benoit, G; Bensadoun, H; Charpentier, B; Fries, D; Hiesse, C; Kriaa, F; Lantz, O; Noury, J | 1 |
| Ades, L; Devergie, A; Esperou, H; Ferry, C; Gluckman, E; Mary, JY; Porcher, R; Ribaud, P; Robin, M; Socié, G; Traineau, R | 1 |
| Azzola, A; Black, J; Chhajed, P; Glanville, A; Havryk, A; Hostettler, K; Johnson, P; Roth, M; Tamm, M | 1 |
| Parekh, K; Patterson, GA; Trulock, E | 1 |
| Broering, DC; Burdelski, M; Ganschow, R; Grabhorn, E; Helmke, K; Hinrichs, B; Rogiers, X; Schulz, A | 1 |
| Arnold, R; Dörken, B; Heine, F; Le Coutre, P; Massenkeil, G; Nagy, M; Rosen, O | 1 |
| Dadlani, C; Orlow, SJ | 1 |
| Bourbigot, B; Budde, K; Campbell, S; Eris, J; Krämer, BK; Krüger, B; Neumayer, HH; Pfalzer, B; Pietrzyk, M; Stahl, R; Vitko, S; Whelchel, J | 1 |
| Amore, A; Cardillo, M; Edefonti, A; Ferraresso, M; Fontana, I; Ghio, L; Ginevri, F; Murer, L; Perfumo, F; Scalamogna, M; Vigano, S; Zacchello, G; Zanon, GF | 1 |
| Boehmer, J; Kovarik, J; Mehra, MR; Michler, R; Vasquez, A; Wagoner, L; Zucker, MJ | 1 |
| Cusimano, RJ; Delgado, DH; Hamel, J; Miriuka, S; Rao, V; Ross, HJ | 1 |
| Csapó, Z; Forgács, B; Kahan, B; Podder, H | 1 |
| Borland, W; Kerr, M; Lockhart, J; Mathias, HC; Murday, AJ; Ozalp, F; Payne, C; Will, MB | 1 |
| García-López, S; Gomollón-García, F; Pérez-Gisbert, J | 1 |
| Burckart, GJ; Corcoran, TE; Dauber, JH; Fung, JJ; Grgurich, WF; Griffith, BP; Iacono, AT; Johnson, BA; McCurry, KR; Seiler, DA; Smaldone, GC; Yousem, SA; Youssef, JG; Zeevi, A | 1 |
| Adalid, C; Barrios, Y; Cano, L; Juarez, FJ; Limones, M; Lopez, E; Martinez, J; Medina, JL; Soria, N | 1 |
| Dengler, T; Giese, T; Konstandin, M; Meuer, S; Schmidt, J; Sommerer, C; Zeier, M | 1 |
| Arce, JA; Bollard, CM; Brenner, MK; Carrum, G; Gottschalk, S; Heslop, HE; Kennedy-Nasser, AA; Khan, SP; Krance, RA; Leung, KS; Mahajan, A; Weiss, HL | 1 |
| Berlakovich, GA; Burghuber, C; Györi, G; Hetz, H; Mühlbacher, F; Silberhumer, G; Soliman, T; Steininger, R | 1 |
| Blanche, S; de Saint Basile, G; Fischer, A; Mahlaoui, N; Neven, B; Ouachée-Chardin, M; Picard, C | 1 |
| Dengler, TJ; Doesch, A; Giese, T; Katus, HA; Konstandin, MH; Meuer, SC; Sommerer, C; Zeier, M | 1 |
| Leleiko, N; LeLeiko, VM; Miller, CM; Moran, V; Rosh, JR; Schwartz, M; Schwersenz, AH | 1 |
| Bechstein, WO; Blumhardt, G; Christe, W; Mueller, AR; Neuhaus, P; Platz, KP; Schattenfroh, N; Stoltenburg-Didinger, G | 1 |
| Bachmann, S; Bechstein, WO; Blumhardt, G; Kahl, A; Mueller, AR; Neuhaus, P; Platz, KP | 1 |
| Browne, BJ; Kahan, BD | 1 |
| Blume, KG; Chao, N; Forman, SJ; Kashyap, A; Long, GD; Margolin, K; Molina, A; Nademanee, A; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Planas, I; Schmidt, GM; Smith, EP; Snyder, DS; Somlo, G; Spielberger, R; Stein, AS; Stepan, DE; Wilsman, K; Zwingenberger, K | 1 |
| Brandt, SA; Edwards, JR; Goodman, S; Greer, JP; Leelasiri, A; Stein, RS; Wolff, SN | 1 |
| Fisher, RA; Lee, HM; Posner, M; Shiffman, ML; Wolfe, L | 1 |
| Hodge, E; Novick, AC; Streem, S; Tanabe, K | 1 |
| Armitage, JM; del Nido, P; Fricker, FJ; Griffith, BP; Hardesty, RL; Starzl, TE | 1 |
| Oliver, GF; Winkelmann, RK | 1 |
| Baxter-Lowe, LA; Bunin, N; Camitta, B; Casper, J; Garbrecht, F; Hunter, J; Lawton, C; Murray, K; Pietryga, D; Truitt, R | 1 |
| Steinhäuslin, F | 1 |
| Billingham, ME; Fowler, MB; Hunt, SA; Moore, KA; Oyer, PE; Sarris, GE; Schroeder, JS; Stinson, EB; Vagelos, RH; Valantine, HB | 1 |
| Burd, RS; Dunn, DL; Granger, DK; Matas, AJ; Schmidt, WJ | 1 |
| Petri, WA | 1 |
| Dehlinger, J; Haverty, TP; Kahana, L; Monaco, A; Norman, DJ; Shield, CF; Stuart, FP; Thistlethwaite, JR; Van Horn, A; Wu, SC | 1 |
| Bennhold, I; Keller, F; Krause, PH; L'age-Stehr, J; Mihatsch, MJ; Offermann, G; Schwarz, A | 1 |
| Anasetti, C; Anderson, JE; Appelbaum, FR; Bensinger, WI; Bryant, E; Buckner, CD; Chauncey, T; Clift, RA; Gooley, T; Schoch, G | 1 |
| Gabor, EP; Lee, S; Mishalani, S | 1 |
| Rigg, KM | 1 |
| Heidenreich, S; Lang, D; Otte, B; Wieneke, H | 1 |
| Benedetti, E; Fryer, JP; Gruessner, A; Gruessner, RW; Hakim, N; Moon, C; Nakhleh, RE; Pirenne, J; Troppmann, C | 1 |
| Brodsky, I; Bulova, S; Crilley, P; Marks, DI; Styler, MJ; Topolsky, D | 1 |
| Belli, L; Civati, G; Corbetta, G; Minetti, L; Ponticelli, C; Quarto di Palo, F; Tarantino, A; Vegeto, A | 1 |
| Barkholt, LM; Dahl, H; Enbom, M; Lindé, A | 1 |
| Blay, JY; Bonnotte, B; Bourhis, JH; Burdiles, AM; Caignard, A; Carayol, G; Chehimi, J; Chouaib, S; Dietrich, PY; Hayat, M; Ibrahim, A; Kubin, M; Pardoux, C; Pico, JL; Robinet, E | 1 |
| Anasetti, C; Appelbaum, FR; Boeckh, M; Chauncey, TR; Deeg, HJ; Doney, K; Flowers, M; Leisenring, W; Lin, D; Martin, P; Nash, R; Schoch, G; Storb, R; Sullivan, KM; Witherspoon, RP | 1 |
| Grauhan, O; Hetzer, R; Hummel, M; Knosalla, C; Loebe, M; Müller, J; Weng, Y | 1 |
| Fritsche, H; Ippoliti, C; Khouri, I; Körbling, M; Przepiorka, D; Warkentin, D; Woo, M | 1 |
| Baroni, A; Cusinato, S; Fabiano, M; Pozzato, M; Salomone, M; Serra, A; Vallero, A | 1 |
| Denfield, SW; Frazier, OH; Gajarski, RJ; Kearney, D; Kertesz, NJ; Price, JK; Radovancevic, B; Rosenblatt, HM; Smith, EO; Towbin, JA | 1 |
| Anasetti, C; Leisenring, W; Sanders, J; Sandmaier, BM; Storb, R; Stucki, A | 1 |
| Kahan, BD; Katz, SM; Meier-Kriesche, HU; Napoli, KL; Podbielski, J; Van Buren, CT | 1 |
| Bradley, JA; Briggs, JD; Junor, BJ; MacPhee, IA; MacPherson, SG; McMillan, MA; Rodger, RS; Watson, MA | 1 |
| Hardie, IR; Johnson, JR; Light, S; Lin, A; Nashan, B | 1 |
| Carreras, E; Marín, P; Martínez, C; Montfort, N; Montserrat, E; Rovira, M; Rozman, C; Sierra, J; Urbano-Ispizua, A | 1 |
| Chong, G; Clot, J; Djamali, A; Leverson, G; Mourad, G; Portales, P; Turc-Baron, C | 1 |
| Elonen, E; Juvonen, E; Parkkali, T; Ruutu, T; Volin, L | 1 |
| Prabhakar, KS; Vathsala, A; Woo, KT | 1 |
| Jonas, S; Klupp, J; Langrehr, JM; Lohmann, R; Neuhaus, P; Neuhaus, R; Raakow, R; Steinmüller, T | 1 |
| McMaster, P | 1 |
| Birsan, T; Klepetko, W; Meiser, B; Reichenspurner, H; Reichert, B; Treede, H; Wisser, W; Zuckermann, A | 1 |
| Fathi, M; Gerbase, MW; Nicod, LP; Spiliopoulos, A | 1 |
| Borka, P; Járay, J; Lázár, N; Perner, F; Remport, A; Sasvári, I; Toronyi, E | 1 |
| Arora, M; Blazar, BR; Davies, SM; Defor, T; Enright, H; Miller, WJ; Wagner, JE; Weisdorf, DF | 1 |
| Ganji, MR; Golbabaie, M; Hakemi, M; Kayedi, M; Mehraban, D; Naderi, GH; Najafi, I | 1 |
| Jawad, F; Naqvi, A; Rizvi, A | 1 |
| Ancín, I; Berlanga, J; Ferrá, C; Gallardo, D; Gonzalez, JR; Grañena, A; Peris, J; Virgili, N | 1 |
| Antin, JH; Bierer, BE; Cowan, MJ; Ho, WG; Jiao, J; Kaizer, H; Lazarus, HM; Linker, C; Miller, KB; Petersen, FB; Petrarca, MA; Schiller, GJ; Small, T; Territo, MC; Tonetta, SA; Wingard, JR; Winston, DJ; Wolff, SN | 1 |
| Gotti, E; Locatelli, G; Perico, N; Remuzzi, G; Rota, G; Ruggenenti, P | 1 |
| Arbeiter, K; Aufricht, C; Balzar, E; Bidmon, B; Müller, T; Ruffingshofer, D | 1 |
| Al-Mousawi, M; Costandi, JN; Gupta, RK; Johny, KV; Muzairai, I; Nampoory, MR; Ninan, VT; Samhan, M | 1 |
| Crilley, P; Styler, M; Teruya, J; Topolsky, D; Verde, S | 1 |
| Albiol, MT; Busquets, J; Fabregat, J; Figueras, J; Ibáñez, L; Jaurrieta, E; Lama, C; Lladó, L; Rafecas, A; Ramos, E; Torras, J | 1 |
| Barry, JM | 1 |
| Handschumacher, RE; High, KP | 1 |
| Boratyńska, M; Szepietowski, T; Szewczyk, Z; Szydłowski, Z | 1 |
| Chung, YC; Hu, RH; Huang, MT; Lee, CJ; Lee, CS; Lee, PH; Tzeng, SS | 1 |
| Bäckman, L; Dati, F; Duraj, FF; Ringdén, O | 1 |
| Belzer, FO; Fox, BC; Kuntz, J; Maki, DG; Sollinger, HW | 1 |
| Remuzzi, G; Ruggenenti, P | 1 |
| Ament, ME; Busuttil, RW; McDiarmid, SV; Millis, MJ; Terasaki, PI | 1 |
23 review(s) available for cyclosporine and Infection
| Article | Year |
|---|---|
Efficacy and safety of cyclosporine a for patients with steroid-resistant nephrotic syndrome: a meta-analysis.
Topics: Cholesterol; Creatinine; Cyclophosphamide; Cyclosporine; Drug Resistance; Gingiva; Humans; Hyperplasia; Hypertension; Immunosuppressive Agents; Infections; Nephrotic Syndrome; Proteinuria; Steroids; Tacrolimus | 2019 |
Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases.
Topics: Adrenal Cortex Hormones; Aged; Antimetabolites; Cyclophosphamide; Cyclosporine; Female; Hematologic Diseases; Herpes Zoster; Humans; Immunosuppressive Agents; Infection Control; Infections; Pneumonia, Pneumocystis; Strongyloidiasis | 2020 |
Risk of infection with different immunosuppressive drugs combined with glucocorticoids for the treatment of idiopathic membranous nephropathy: A pairwise and network meta-analysis.
Topics: China; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Infections; Kidney Failure, Chronic; Randomized Controlled Trials as Topic; Risk; Tacrolimus | 2019 |
T-cell co-stimulatory blockade in transplantation: two steps forward one step back!
Topics: Abatacept; Animals; B7-1 Antigen; B7-2 Antigen; CD28 Antigens; Clinical Trials as Topic; Costimulatory and Inhibitory T-Cell Receptors; Cyclosporine; Disease Susceptibility; Graft Enhancement, Immunologic; Graft Rejection; Graft Survival; Humans; Immunoconjugates; Immunologic Memory; Immunosuppressive Agents; Infections; Kidney Diseases; Lymphocyte Activation; Lymphoproliferative Disorders; Molecular Targeted Therapy; Multicenter Studies as Topic; Postoperative Complications; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Th17 Cells; Transplantation Immunology | 2013 |
Long-term safety of mycophenolate mofetil and cyclosporine: a review.
Topics: Adult; Cyclosporine; Dermatologic Agents; Female; Humans; Immunosuppressive Agents; Infections; Long-Term Care; Mycophenolic Acid; Neoplasms; Pregnancy; Psoriasis; Safety | 2008 |
Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis.
Topics: Adult; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Infections; Lung Transplantation; Odds Ratio; Postoperative Complications; Randomized Controlled Trials as Topic; Registries; Survival Rate; Tacrolimus; Treatment Outcome | 2009 |
Thrombotic thrombocytopenic purpura: a hematological emergency.
Topics: ADAM Proteins; ADAMTS13 Protein; Antibodies, Monoclonal, Murine-Derived; Autoimmune Diseases; Cyclosporine; Female; Glucocorticoids; Hemolytic-Uremic Syndrome; Humans; Immunologic Factors; Immunosuppressive Agents; Infections; Neoplasms; Plasma Exchange; Platelet Transfusion; Pregnancy; Pregnancy Complications, Hematologic; Prognosis; Purpura, Thrombotic Thrombocytopenic; Renal Dialysis; Rituximab | 2012 |
Diagnosing and treating hemophagocytic lymphohistiocytosis in the tropics: systematic review from the Indian subcontinent.
Topics: Cyclosporine; Etoposide; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; India; Infections; Lymphohistiocytosis, Hemophagocytic; Steroids; Tropical Climate | 2012 |
Influence of one human leukocyte antigen mismatch on outcome of allogeneic bone marrow transplantation from related donors.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Family; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Histocompatibility Testing; HLA Antigens; Host vs Graft Reaction; Humans; Infections; Male; Methotrexate; Middle Aged; Parents; Risk; Siblings; Survival Analysis; Survival Rate; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2003 |
Use of cyclosporine in lung transplantation.
Topics: Acute Disease; Calcineurin Inhibitors; Chemistry, Pharmaceutical; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Infections; Lung Transplantation; Neoplasms; Postoperative Complications | 2004 |
Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature.
Topics: Adolescent; Age Factors; Autoimmune Diseases; Child; Child, Preschool; Cyclosporine; Disease Susceptibility; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Infections; Lymphoma; Male; Methotrexate; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Rheumatic Diseases; Skin Diseases | 2005 |
Cyclosporine in the treatment of severe attack of ulcerative colitis: a systematic review.
Topics: Administration, Oral; Adrenal Cortex Hormones; Azathioprine; Clinical Trials as Topic; Colitis, Ulcerative; Controlled Clinical Trials as Topic; Cyclosporine; Disease Susceptibility; Drug Resistance; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Infections; Infusions, Intravenous; Research Design; Seizures; Treatment Outcome | 2005 |
Transplantation 1994: the year in review.
Topics: Clinical Trials as Topic; Cyclosporine; Disease Susceptibility; Emulsions; Global Health; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Life Tables; Multicenter Studies as Topic; Neoplasms; Organ Transplantation; Postoperative Complications; Public Opinion; Tissue and Organ Procurement; Treatment Outcome | 1994 |
Treatment of lichen planus.
Topics: Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Cyclosporine; Humans; Infections; Lichen Planus; Retinoids; Steroids | 1993 |
Infections in heart transplant recipients.
Topics: Anti-Bacterial Agents; Arteriosclerosis; Central Nervous System Diseases; Cyclosporine; Cytomegalovirus Infections; Heart Transplantation; Heart-Assist Devices; Humans; Infections; Lymphoproliferative Disorders; Pneumonia; Time Factors; Tissue Donors | 1994 |
The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation--data on four cases and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cyclosporine; Female; Graft Rejection; HIV-1; Humans; Immunocompromised Host; Infections; Kidney Transplantation; Male; Middle Aged | 1993 |
Renal transplantation: current status, complications and prevention.
Topics: Animals; Cyclosporine; Graft Rejection; Humans; Infections; Kidney; Kidney Transplantation; Postoperative Complications; Tissue and Organ Procurement | 1995 |
[Performance and postoperative care of heart transplantation].
Topics: Anti-Inflammatory Agents; Azathioprine; Biopsy; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Infections; Myocardium; Postoperative Complications; Prednisolone; Time Factors; Tissue Donors | 1997 |
Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Adult; Chemical and Drug Induced Liver Injury; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Hyperglycemia; Hyperkalemia; Hypertension; Immunosuppressive Agents; Incidence; Infections; Male; Methylprednisolone; Middle Aged; Patient Compliance; Retrospective Studies; Seizures; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 1997 |
Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Contraindications; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Infections; Leukemia; Male; Middle Aged; Multiple Organ Failure; Plasma Exchange; Platelet Transfusion; Purpura, Thrombotic Thrombocytopenic; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Treatment Failure | 2001 |
Immunosuppressive drugs in renal transplantation. A review of the regimens.
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunocompromised Host; Immunosuppressive Agents; Infections; Kidney Transplantation; Neoplasms; Prednisolone; Tacrolimus | 1992 |
Immunity, microbial pathogenesis, and immunophilins: finding the keys, now where are the locks?
Topics: Amino Acid Isomerases; Animals; Anti-Bacterial Agents; Carrier Proteins; Cyclosporine; DNA-Binding Proteins; Heat-Shock Proteins; Humans; Immunity; Immunosuppressive Agents; Infections; Lymphocyte Activation; Peptidylprolyl Isomerase; Polyenes; Sirolimus; Tacrolimus; Tacrolimus Binding Proteins; Virulence | 1992 |
Thrombotic microangiopathies.
Topics: Adult; Child; Cyclosporine; Endothelium, Vascular; Female; Genetic Predisposition to Disease; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Infections; Kidney; Kidney Transplantation; Microcirculation; Neoplasms; Plasma Exchange; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, Hematologic; Purpura, Thrombotic Thrombocytopenic; Thrombosis | 1991 |
43 trial(s) available for cyclosporine and Infection
| Article | Year |
|---|---|
Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study.
Topics: Adult; Aged; Allografts; Anti-Inflammatory Agents; Cannabidiol; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Prospective Studies; Young Adult | 2015 |
Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.
Topics: Adult; Aged; Calcineurin Inhibitors; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Infections; Male; Middle Aged; Mycophenolic Acid; Premedication; Sirolimus; Survival Analysis; Time Factors; Transplantation Conditioning; Young Adult | 2016 |
Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial.
Topics: Abatacept; Adult; Calcineurin Inhibitors; Cyclosporine; Drug Substitution; Female; Graft Rejection; Graft Survival; Humans; Immunocompromised Host; Immunosuppressive Agents; Infections; Kidney Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Mortality; Neoplasms; Tacrolimus; Treatment Outcome | 2017 |
A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis.
Topics: Adult; Alefacept; CD4 Lymphocyte Count; Cyclosporine; Dermatologic Agents; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Infections; Lymphopenia; Male; Methotrexate; Middle Aged; Neoplasms; Psoriasis; Recombinant Fusion Proteins; Retinoids; Retreatment; Treatment Outcome; Ultraviolet Therapy | 2008 |
Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Calcineurin Inhibitors; Cyclosporine; Daclizumab; Delayed Graft Function; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Infections; Kidney Transplantation; Lipid Metabolism; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Sirolimus; Tacrolimus; Treatment Outcome | 2010 |
Antithymocyte globulin induction therapy for adult heart transplantation: a UK national study.
Topics: Adult; Antilymphocyte Serum; Cause of Death; Cyclosporine; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Infections; Male; Middle Aged; Prospective Studies; Survival Rate; Treatment Outcome; United Kingdom | 2011 |
Randomized trial of immunosuppressive regimens in renal transplantation.
Topics: Adolescent; Adult; Aged; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Dyslipidemias; Female; Florida; Graft Rejection; Guideline Adherence; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Young Adult | 2011 |
Pharmacodynamic monitoring by residual NFAT-regulated gene expression in stable pediatric liver transplant recipients.
Topics: Adolescent; Biomarkers; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Female; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Infections; Interferon-gamma; Interleukin-2; Liver Transplantation; Male; NFATC Transcription Factors; Prospective Studies; Real-Time Polymerase Chain Reaction; T-Lymphocytes; Tacrolimus; Young Adult | 2012 |
The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclosporine; Disease-Free Survival; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infections; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Sirolimus; Survival Rate; Tacrolimus; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Young Adult | 2013 |
One-year follow-up of a Brazilian randomized multicenter study comparing tacrolimus versus cyclosporine in kidney transplantation.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Brazil; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Infections; Kidney Transplantation; Male; Postoperative Complications; Protozoan Infections; Tacrolimus; Time Factors | 2002 |
Use of rapamycin slows progression of cardiac transplantation vasculopathy.
Topics: Arterial Occlusive Diseases; Autoantibodies; Cardiac Catheterization; Cohort Studies; Coronary Artery Disease; Cyclosporine; Disease Progression; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Infections; Male; Middle Aged; Neoplasms; Prospective Studies; Renal Insufficiency; Sirolimus; Survival Analysis; Treatment Outcome | 2003 |
Reduction of immunosuppressant therapy requirement in heart transplantation by calcitriol.
Topics: Bone Density; Calcitriol; Calcium; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Heart Transplantation; Humans; Immunosuppressive Agents; Infections; Postoperative Complications; Prednisolone; Retrospective Studies | 2003 |
Prophylactic use of the IL-2 receptor-specific monoclonal antibody LO-Tact-1 with cyclosporin A and steroids in renal transplantation.
Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Immunosuppressive Agents; Infections; Kidney Transplantation; Postoperative Complications; Probability; Rats; Receptors, Interleukin-2; Survival Rate; Time Factors | 1992 |
Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximab.
Topics: Antibodies, Monoclonal; Basiliximab; Blood Pressure; Cardiovascular Diseases; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Glomerular Filtration Rate; Gonadal Steroid Hormones; Graft Rejection; Humans; Immunosuppressive Agents; Infections; Kidney Function Tests; Kidney Transplantation; Male; Postoperative Complications; Recombinant Fusion Proteins; Risk Factors; Sirolimus | 2005 |
Pharmacokinetic of cyclosporine microemulsion in pediatric kidney recipients receiving A quadruple immunosuppressive regimen: the value of C2 blood levels.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Basiliximab; Biomarkers; Child; Complement C2; Cyclosporine; Drug Therapy, Combination; Emulsions; Female; Graft Rejection; Humans; Immunosuppressive Agents; Infections; Kidney Transplantation; Male; Postoperative Complications; Recombinant Fusion Proteins | 2005 |
A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Basiliximab; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Infections; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Postoperative Period; Receptors, Interleukin-2; Recombinant Fusion Proteins; United States | 2005 |
Monitoring of cyclosporine 2-hour post-dose levels in heart transplantation: improvement in clinical outcomes.
Topics: Adult; Aged; Area Under Curve; Creatinine; Cyclosporine; Drug Monitoring; Female; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Infections; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2005 |
A randomized, controlled trial of C0- Vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients.
Topics: Aged; Area Under Curve; Creatinine; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Infections; Male; Middle Aged; Monitoring, Physiologic; Postoperative Complications; Prospective Studies; Survival Analysis | 2005 |
A randomized trial of inhaled cyclosporine in lung-transplant recipients.
Topics: Acute Disease; Administration, Inhalation; Chronic Disease; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Infections; Lung Transplantation; Male; Middle Aged; Multivariate Analysis; Regression Analysis; Survival Analysis | 2006 |
A randomized trial comparing two corticosteroid regimens combined with mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection.
Topics: Adrenal Cortex Hormones; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Infections; Kidney Transplantation; Leukopenia; Mycophenolic Acid; Postoperative Complications; Transplantation, Homologous; Treatment Outcome | 2006 |
Therapy with FK 506 in pediatric liver recipients.
Topics: Adolescent; Bilirubin; Child; Child, Preschool; Cyclosporine; Female; Graft Survival; Humans; Hyperkalemia; Immunosuppression Therapy; Infant; Infections; Liver Transplantation; Lymphoproliferative Disorders; Male; Safety; Tacrolimus | 1994 |
Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506.
Topics: Adolescent; Adult; Aged; Blood Chemical Analysis; Brain; Brain Diseases; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppression Therapy; Infections; Liver Transplantation; Male; Middle Aged; Multiple Organ Failure; Reoperation; Tacrolimus | 1994 |
Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Cyclosporine; Female; Graft Rejection; Humans; Infections; Kidney Function Tests; Liver Transplantation; Male; Middle Aged; Multiple Organ Failure; Renal Dialysis; Tacrolimus | 1994 |
Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Incidence; Infections; Liver Transplantation; Male; Middle Aged; Survival Rate; Tacrolimus | 1994 |
Thalidomide as salvage therapy for chronic graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Chronic Disease; Constipation; Cyclosporine; Drug Eruptions; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Infections; Leukemia; Male; Middle Aged; Neuritis; Neutropenia; Prednisone; Remission Induction; Salvage Therapy; Survival Rate; Thalidomide; Treatment Outcome | 1995 |
Graft-versus-host-disease prophylaxis for matched unrelated donor bone marrow transplantation: comparison between cyclosporine-methotrexate and cyclosporine-methotrexate-methylprednisolone.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Histocompatibility; Humans; Incidence; Infections; Male; Methotrexate; Methylprednisolone; Survival Rate | 1995 |
A randomized clinical trial of induction therapy with OKT3 in kidney transplantation.
Topics: Adolescent; Adult; Aged; Antibody Formation; Azathioprine; Child; Cyclosporine; Drug Administration Schedule; Female; Graft Rejection; Graft Survival; Humans; Infections; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Neoplasms; Prospective Studies; Succinates; Succinic Acid; Time Factors; Transplantation Immunology | 1993 |
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Infections; Karyotyping; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prognosis; Recurrence; Regression Analysis; Survival Rate; Treatment Outcome; Whole-Body Irradiation | 1996 |
Randomized study with cyclosporine in kidney transplantation: 10-year follow-up.
Topics: Adolescent; Adult; Azathioprine; Cataract; Child; Creatinine; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Infections; Kidney Diseases; Kidney Transplantation; Life Tables; Male; Middle Aged; Neoplasms; Postoperative Complications; Survival Rate; Treatment Outcome | 1996 |
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Infant; Infections; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Respiratory Insufficiency; Transplantation Conditioning; Treatment Outcome | 1997 |
Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation.
Topics: Adult; Aged; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Infections; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prednisone; Sirolimus | 1998 |
Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Azathioprine; Blood Pressure; Cardiovascular Diseases; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Infections; Kidney; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome | 1998 |
Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cadaver; Cyclosporine; Daclizumab; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Infections; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Transplantation, Homologous | 1999 |
Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study.
Topics: Acute Disease; Adolescent; Adult; Blood Transfusion; Bone and Bones; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Hospitalization; Humans; Infections; Male; Methotrexate; Methylprednisolone; Middle Aged; Necrosis; Nuclear Family; Prospective Studies; Recurrence; Survival Rate | 2000 |
Patient and graft survival in the European Multicentre Liver Study--FK 506 vs cyclosporin A.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Humans; Immunosuppressive Agents; Infections; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Survival Rate; Tacrolimus; Time Factors | 1994 |
Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols.
Topics: Acute Disease; Adult; Aged; Bronchiolitis Obliterans; Chronic Disease; Creatinine; Cyclosporine; Drug Combinations; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Infections; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Survival Rate; Tacrolimus; Time Factors; Treatment Outcome | 2001 |
Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation.
Topics: Adult; Analysis of Variance; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Infections; Lung Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Prednisone; Tacrolimus; Time Factors | 2001 |
Mycofenolate mofetil-cyclosporine immunosuppression of kidney transplantation recipients with two different corticosteroid doses.
Topics: Adrenal Cortex Hormones; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Infections; Kidney Transplantation; Leukopenia; Male; Mycophenolic Acid; Opportunistic Infections; Postoperative Complications; Prednisolone; Survival Rate | 2001 |
Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease.
Topics: Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infections; Prednisone; Prognosis; Risk Factors; Salvage Therapy; Survival Analysis; Thalidomide; Transplantation, Homologous; Treatment Outcome | 2001 |
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Infections; Leukemia; Lymphocyte Depletion; Lymphoma; Male; Methotrexate; Middle Aged; Survival Analysis; Time Factors; Tissue Donors; Transplantation, Homologous | 2001 |
The kidney transplant program at the Bergamo Center.
Topics: Academic Medical Centers; Animals; Calcineurin; Cyclosporine; Genetic Therapy; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; In Vitro Techniques; Infections; Italy; Kidney Transplantation; Mycophenolic Acid; Neoplasms; Randomized Controlled Trials as Topic; Renal Artery Obstruction; Survival Rate; Swine; Tissue and Organ Procurement; Transplantation, Heterologous | 2000 |
A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine.
Topics: Creatinine; Cyclosporine; Double-Blind Method; Drug Interactions; Humans; Infections; Kidney Diseases; Kidney Transplantation; Patient Compliance; Postoperative Complications; Prospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
OKT3 prophylaxis in liver transplantation.
Topics: Adult; Antibody Formation; Antigens, Differentiation, T-Lymphocyte; Azathioprine; CD3 Complex; Child; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Incidence; Infections; Kidney Function Tests; Liver Transplantation; Middle Aged; Muromonab-CD3; Prospective Studies; Receptors, Antigen, T-Cell; Reoperation; Steroids; Survival Rate; T-Lymphocytes | 1991 |
60 other study(ies) available for cyclosporine and Infection
| Article | Year |
|---|---|
Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience.
Topics: Adult; Allografts; Antilymphocyte Serum; Cyclosporine; Disease-Free Survival; Dose-Response Relationship, Immunologic; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Incidence; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Recurrence; Retrospective Studies; T-Lymphocytes; Unrelated Donors | 2021 |
Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infections; Infliximab; Male; Middle Aged; Mortality; Registries; Severity of Illness Index; Treatment Outcome; Young Adult | 2017 |
Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Animals; Antilymphocyte Serum; Child; Cyclosporine; Drug Therapy, Combination; Female; France; Hemorrhage; Horses; Humans; Infections; Male; Middle Aged; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2018 |
Immunosuppressive therapy for aplastic anemia: a single-center experience from western India.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Chemotherapy-Induced Febrile Neutropenia; Child; Cyclosporine; Disease-Free Survival; Female; Humans; Hypertension; Immunosuppression Therapy; India; Infections; Intracranial Hemorrhages; Male; Retrospective Studies; Survival Rate | 2019 |
Evaluating the Efficacy and Anti-infective Effect of High-dose Intravenous Immunoglobulin Adjuvant Therapy for Acquired Aplastic Anemia Children.
Topics: Anemia, Aplastic; Animals; Anti-Infective Agents; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Female; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Infection Control; Infections; Male; Rabbits; Retrospective Studies | 2019 |
Clinical outcomes of immunosuppressive therapy for severe aplastic anemia patients with absolute neutrophil count of zero.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infections; Kaplan-Meier Estimate; Leukocyte Count; Male; Middle Aged; Neutrophils; Prognosis; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
Prevalence of past and reactivated viral infections and efficacy of cyclosporine A as monotherapy or in combination in patients with psoriatic arthritis--synergy study: a longitudinal observational study.
Topics: Adult; Antibodies, Viral; Arthritis, Psoriatic; Cyclosporine; Drug Synergism; Female; Humans; Infections; Longitudinal Studies; Male; Middle Aged; Seroepidemiologic Studies; Viruses | 2014 |
Consensus on the use of cyclosporine in dermatological practice. Italian Consensus Conference.
Topics: Adult; Child; Cyclosporine; Dermatitis, Atopic; Disease Susceptibility; Drug Administration Schedule; Drug Interactions; Female; Food-Drug Interactions; Humans; Hypertension; Immunosuppressive Agents; Infections; Kidney Diseases; Neoplasms; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Psoriasis; Quality of Life; Skin Diseases | 2014 |
Infectious complications following allogeneic stem cell transplantation by using anti-thymocyte globulin-based myeloablative conditioning regimens in children with hemoglobinopathies.
Topics: Adolescent; Anemia, Sickle Cell; Antilymphocyte Serum; Bacteremia; beta-Thalassemia; Child; Cohort Studies; Cyclosporine; Cystitis; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Humans; Immunocompromised Host; Immunosuppressive Agents; Infections; Male; Pneumonia, Pneumocystis; Retrospective Studies; Toxoplasmosis; Transplantation Conditioning; Viremia | 2015 |
Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation.
Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Infections; Kidney; Kidney Function Tests; Male; Middle Aged; Polymorphism, Single Nucleotide; Tacrolimus; Tissue Donors | 2015 |
Congenital Infections in Neonates of Women With Liver or Kidney Transplants.
Topics: Adult; Azathioprine; Cyclosporine; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant, Newborn; Infections; Kidney Transplantation; Liver Transplantation; Male; Pregnancy; Pregnancy Complications; Retrospective Studies; Tacrolimus; Transplantation, Homologous | 2016 |
Living related donor kidney transplantation in Libya: a single center experience.
Topics: Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infections; Kidney Transplantation; Libya; Living Donors; Male; Postoperative Complications; Postoperative Period; Retrospective Studies; Sex Characteristics | 2008 |
Pharmacodynamic monitoring of cyclosporine A by NFAT-regulated gene expression and the relationship with infectious complications in pediatric renal transplant recipients.
Topics: Adolescent; Adult; Area Under Curve; Child; Child, Preschool; Cyclosporine; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Immunosuppressive Agents; Infections; Kidney Transplantation; Lymphocytes; Male; NFATC Transcription Factors; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Immunosuppressive therapy allows recovery from liver failure in children with autoimmune hepatitis.
Topics: Adolescent; Bilirubin; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; gamma-Globulins; gamma-Glutamyltransferase; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Infections; Liver Failure; Liver Transplantation; Male; Prednisone; Prothrombin Time; Retrospective Studies; Transaminases | 2011 |
An integrated safety profile analysis of belatacept in kidney transplant recipients.
Topics: Abatacept; Clinical Trials as Topic; Cyclosporine; Follow-Up Studies; Humans; Immunoconjugates; Immunosuppressive Agents; Infections; Kidney Transplantation; Postoperative Complications; Time Factors | 2010 |
Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis.
Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Child; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Humans; Infections; Infliximab; Injections, Intravenous; Male; Middle Aged; Pulmonary Embolism; Retrospective Studies; Salvage Therapy; Steroids; Treatment Outcome; Young Adult | 2011 |
Immunization in children with chronic renal failure.
Topics: Adolescent; Adult; Antibody Formation; Chickenpox; Child; Child, Preschool; Cyclosporine; Female; Haemophilus Infections; Humans; Immunization; Immunization Schedule; Immunosuppressive Agents; Infections; Influenza, Human; Kidney Failure, Chronic; Kidney Transplantation; Male; Pneumococcal Infections; Treatment Failure | 2002 |
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Infections; Life Tables; Lymphoproliferative Disorders; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Spain; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; United Kingdom; Vidarabine | 2002 |
Baboons undergoing orthotopic concordant cardiac xenotransplantation surviving more than 300 days: effect of immunosuppressive regimen.
Topics: Actuarial Analysis; Animals; Antilymphocyte Serum; Bone Marrow Transplantation; Cyclosporine; Graft Rejection; Heart Transplantation; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Macaca mulatta; Methotrexate; Papio; Splenectomy; Tacrolimus; Time Factors; Transplantation, Heterologous | 2003 |
Report of a child with vitiligo and Evans syndrome.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Anticardiolipin; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoimmune Diseases; Child, Preschool; Cyclosporine; Eczema; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infections; Male; Milk Hypersensitivity; Prednisone; Rituximab; Salmonella Infections; Syndrome; Thrombocytopenia; Vitiligo; Zidovudine | 2003 |
High incidence of severe infections in heart transplant recipients receiving tacrolimus.
Topics: Aged; Azathioprine; Cyclosporine; Drug Therapy, Combination; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Infections; Male; Middle Aged; Postoperative Complications; Prednisone; Retrospective Studies; Tacrolimus | 2003 |
Long-term outcome after bone marrow transplantation for severe aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Female; Follow-Up Studies; Humans; Incidence; Infections; Male; Neoplasms, Second Primary; Retrospective Studies; Survival Analysis; Time Factors; Tissue Donors; Treatment Outcome; Whole-Body Irradiation | 2004 |
Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.
Topics: Adult; Aged; Azathioprine; Bronchi; Bronchiolitis Obliterans; Cell Division; Cells, Cultured; Cyclosporine; Everolimus; Female; Fibroblasts; Humans; Immunosuppressive Agents; Infections; Lung Diseases; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Sirolimus; Tacrolimus | 2004 |
Short- and long-term results of liver transplantation in infants aged less than 6 months.
Topics: Body Weight; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Infections; Liver Diseases; Liver Transplantation; Male; Methylprednisolone; Postoperative Complications; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome | 2004 |
Nonmyeloablative stem cell transplantation in patients with ALL and AML results in low nonrelapse mortality despite high rate of infections and GVHD.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Busulfan; Contraindications; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infection Control; Infections; Leukemia, Myeloid; Male; Middle Aged; Mycophenolic Acid; Mycoses; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk; Survival Rate; T-Lymphocytes; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2004 |
[Improved outcome with sirolimus-cyclosporine regimen in high-risk renal transplant recipients].
Topics: Acute Disease; Adult; Black or African American; Cyclosporine; Female; Graft Rejection; Hispanic or Latino; Humans; Immunosuppressive Agents; Incidence; Infections; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Risk Assessment; Sirolimus; Texas; Treatment Outcome; White People | 2005 |
Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies.
Topics: Adult; Aged; Analysis of Variance; Cyclosporine; Drug Monitoring; Female; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Interferon-gamma; Interleukin-2; Kidney Transplantation; Male; Middle Aged; Neoplasms; NFATC Transcription Factors; Postoperative Complications; Recurrence | 2006 |
Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.
Topics: Adolescent; Alemtuzumab; Anemia, Aplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Histocompatibility; Humans; Immunosuppressive Agents; Infant; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Retrospective Studies; Siblings; Survival Analysis; T-Lymphocyte Subsets; Tacrolimus; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2006 |
Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation.
Topics: Adult; Antilymphocyte Serum; Cyclosporine; Drug Administration Schedule; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Infections; Liver Diseases; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies | 2007 |
Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients.
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Immunotherapy; Infections; Injections, Spinal; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Methotrexate; Methylprednisolone; Recurrence; Retrospective Studies; Treatment Outcome | 2007 |
Pharmacodynamic cyclosporine A-monitoring: relation of gene expression in lymphocytes to cyclosporine blood levels in cardiac allograft recipients.
Topics: Aged; Cyclosporine; Female; Gene Expression; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Infections; Lymphocytes; Male; Middle Aged; NFATC Transcription Factors | 2007 |
Induction with OKT3 and prostaglandin E1 in liver transplantation.
Topics: Adult; Aged; Alprostadil; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Infections; Infusions, Intravenous; Liver Transplantation; Lymphocyte Count; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Prospective Studies; Reoperation; Survival Rate | 1994 |
Long-term renal function in cyclosporine-treated renal allograft recipients.
Topics: Adult; Azathioprine; Chi-Square Distribution; Creatinine; Cyclosporine; Female; Graft Rejection; Humans; Hypercholesterolemia; Infections; Kidney; Kidney Transplantation; Male; Middle Aged; Prednisone; Proteinuria; Survival Analysis | 1995 |
A decade (1982 to 1992) of pediatric cardiac transplantation and the impact of FK 506 immunosuppression.
Topics: Adolescent; Cardiomyopathies; Child; Child, Preschool; Cyclosporine; Extracorporeal Membrane Oxygenation; Female; Graft Rejection; Heart Defects, Congenital; Heart Transplantation; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Infections; Kidney; Lymphoproliferative Disorders; Male; Postoperative Complications; Tacrolimus | 1993 |
Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia.
Topics: Actuarial Analysis; Adolescent; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Histocompatibility; Humans; Infections; Leukemia; Lung Diseases, Interstitial; Male; Methylprednisolone; Myelodysplastic Syndromes; Retrospective Studies; Risk Factors; Survival Analysis; Tissue Donors; Treatment Outcome; Whole-Body Irradiation; Wisconsin | 1995 |
[After care following kidney transplantation].
Topics: Adrenal Cortex Hormones; Azathioprine; Cardiovascular Diseases; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Infections; Kidney Neoplasms; Kidney Transplantation; Postoperative Care; Postoperative Complications | 1994 |
Cardiac transplantation: the Stanford experience in the cyclosporine era.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Child; Child, Preschool; Coronary Disease; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Infant; Infections; Logistic Models; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Survival Analysis | 1994 |
Incidence and timing of infections in pediatric renal transplant recipients in the cyclosporine era.
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cyclosporine; Cytomegalovirus Infections; Humans; Immunosuppression Therapy; Infections; Kidney Transplantation; Mycoses; Time Factors; Urinary Tract Infections | 1994 |
Rapid response to cyclosporine therapy and sustained remission in large granular lymphocyte leukemia.
Topics: Adult; Agranulocytosis; Combined Modality Therapy; Cyclosporine; Dexamethasone; Female; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Immunosuppressive Agents; Infections; Leukemia-Lymphoma, Adult T-Cell; Remission Induction | 1996 |
Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
Topics: Antilymphocyte Serum; Azathioprine; Case-Control Studies; CD4 Lymphocyte Count; Cyclosporine; Female; Graft Rejection; Humans; Immunoglobulin G; Immunoglobulins; Immunosuppressive Agents; Infections; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Predictive Value of Tests; Prednisolone; Renal Dialysis; T-Lymphocyte Subsets; T-Lymphocytes | 1996 |
Combined transplantation of small and large bowel. FK506 versus cyclosporine A in a porcine model.
Topics: Animals; Body Weight; Cyclosporine; Endotoxins; Graft Rejection; Graft vs Host Disease; Immunosuppressive Agents; Infections; Intestine, Large; Intestine, Small; Prospective Studies; Swine; Tacrolimus; Toxemia | 1996 |
Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
Topics: Actuarial Analysis; Acute Disease; Adult; Anti-Infective Agents; Bone Marrow Transplantation; Busulfan; Cause of Death; Critical Care; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Histocompatibility; HLA-DR Antigens; Humans; Immunosuppressive Agents; Infections; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Risk; Survival Analysis; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1996 |
Epstein-Barr virus DNA in serum after liver transplantation--surveillance of viral activity during treatment with different immunosuppressive agents.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antigens, Viral; Child; Child, Preschool; Cyclosporine; DNA, Viral; Female; Graft Rejection; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Incidence; Infant; Infections; Liver Transplantation; Lymphoma, B-Cell; Male; Middle Aged; Muromonab-CD3; Polymerase Chain Reaction; Postoperative Complications; Postoperative Period; Survival Rate; Tacrolimus; Tumor Virus Infections; Viral Proteins; Viremia; Virus Activation | 1996 |
Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Infections; Interleukin-12; Male; Methotrexate; Middle Aged; Transplantation, Autologous; Transplantation, Homologous | 1996 |
[Critical review of renal transplantation data from the Piedmontese Regional Dialysis and Transplantation Registry].
Topics: Adolescent; Adult; Cardiovascular Diseases; Cause of Death; Child; Child, Preschool; Cyclosporine; Drug Utilization; Female; Humans; Immunosuppressive Agents; Infant; Infections; Italy; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Neoplasms; Registries; Reoperation; Survival Analysis | 1998 |
Long-term results of triple-drug-based immunosuppression in nonneonatal pediatric heart transplant recipients.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Coronary Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Infant; Infections; Longitudinal Studies; Male; Postoperative Care; Postoperative Complications; Prednisone; Risk Factors; Survival Analysis | 1998 |
Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis).
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Infections; Life Tables; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Survival Rate; Transplantation, Homologous | 1998 |
Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts.
Topics: Adolescent; Adult; Antigens, CD19; Antigens, CD34; B-Lymphocyte Subsets; CD4 Antigens; CD8 Antigens; Cell Separation; Chimera; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Infections; Killer Cells, Natural; Kinetics; Leukapheresis; Leukocyte Common Antigens; Lymphocyte Count; Lymphocyte Depletion; Lymphocyte Subsets; Male; Methotrexate; Methylprednisolone; Middle Aged; Prospective Studies; T-Lymphocyte Subsets; Time Factors; Transplantation Conditioning; Whole-Body Irradiation | 1999 |
Low dose antithymocyte globulins in renal transplantation: daily versus intermittent administration based on T-cell monitoring.
Topics: Adult; Aged; Animals; Antilymphocyte Serum; Blood Cells; Clonal Deletion; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft Rejection; Health Care Costs; Hematologic Diseases; Humans; Immunosuppressive Agents; Infections; Kidney; Kidney Transplantation; Lymphocytes; Male; Middle Aged; Rabbits | 2000 |
Long-term outcome of living-unrelated donor kidney transplantation.
Topics: Adult; Azathioprine; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Family; Female; Graft Survival; Humans; Immunosuppressive Agents; India; Infections; Kidney Transplantation; Living Donors; Male; Methylprednisolone; Postoperative Complications; Prednisolone; Singapore; Survival Rate; Time Factors; Treatment Failure; Treatment Outcome | 2000 |
Impact of primary immunosuppression on the incidence of infectious complications after orthotopic liver transplantation.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infections; Liver Transplantation; Male; Postoperative Complications; Prednisolone; Retrospective Studies; Time Factors | 2000 |
Chronic renal allograft dysfunction: immunologic and nonimmunologic risk factors.
Topics: Acute Disease; Adolescent; Adult; Child; Creatinine; Cyclosporine; Female; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Infections; Iran; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Regression Analysis; Risk Factors; Transplantation, Homologous | 2001 |
High dose steroid regime: a tool for reducing organ rejection.
Topics: Adult; Azathioprine; Cyclosporine; Diabetes Mellitus; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Infections; Kidney Transplantation; Male; Methylprednisolone; Postoperative Complications; Retrospective Studies; Survival Rate | 2001 |
Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT?
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cause of Death; Cyclosporine; Female; Gastrointestinal Hemorrhage; Graft vs Host Disease; Hematologic Neoplasms; Humans; Hypertension; Infections; Male; Methotrexate; Middle Aged; Musculoskeletal Diseases; Prednisone; Retrospective Studies; Survival Analysis; Therapeutic Equivalency; Transplantation, Homologous | 2001 |
Reduction of delayed renal allograft function using sequential immunosuppression.
Topics: Antibodies; Azathioprine; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Hypertension; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infant; Infections; Kidney; Kidney Transplantation; Male; Postoperative Complications; Prednisone; Time Factors | 2001 |
High incidence of post-transplant diabetes mellitus in Kuwait.
Topics: Adult; Azathioprine; Cause of Death; Coronary Disease; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Infections; Kidney Transplantation; Kuwait; Male; Middle Aged; Prednisone; Survival Rate | 2002 |
Immunosuppression with calcineurin inhibitors and polyclonal antibodies in liver transplantation.
Topics: Antibodies; Antilymphocyte Serum; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Liver Transplantation; Postoperative Complications; Prednisone; Retrospective Studies; Tacrolimus; Time Factors | 2002 |
Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients.
Topics: Acute Disease; Acute Kidney Injury; Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Incidence; Infections; Ischemia; Kidney; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Phlebitis; Postoperative Complications; Prednisone; Survival Rate; Thrombocytopenia; Transplantation, Homologous | 1992 |
Monitoring of serum neopterin in renal transplant recipients.
Topics: Adult; Biopterins; Cyclosporine; Female; Graft Rejection; Humans; Infections; Kidney; Kidney Transplantation; Male; Middle Aged; Neopterin; Time Factors | 1992 |
Serum levels of alpha-1 microglobulin and beta-2 microglobulin in bone marrow transplant recipients treated with cyclosporin A.
Topics: Adolescent; Adult; Alpha-Globulins; beta 2-Microglobulin; Bone Marrow Transplantation; Child; Creatinine; Cyclosporine; Female; Graft vs Host Disease; Humans; Infections; Kidney; Kidney Diseases; Male; Middle Aged; Protease Inhibitors | 1991 |